Difference between revisions of "Team:Tuebingen/Basic Part"

 
(11 intermediate revisions by 4 users not shown)
Line 11: Line 11:
 
     padding: 0;
 
     padding: 0;
 
}
 
}
 +
 +
Css->
 +
 +
    #ImpressumSponsoren{
 +
            bottom:0px;
 +
            margin-left: 25em;
 +
            margin-bottom: 5em;
 +
            margin-right: 10em;
 +
            text-align: right;
 +
        }
  
 
#BigImageLab{
 
#BigImageLab{
Line 126: Line 136:
 
     grid-template-rows: auto;
 
     grid-template-rows: auto;
 
     margin-bottom: 5em;
 
     margin-bottom: 5em;
−
     margin-top: -18em;
+
     margin-top: -25em;
 
    
 
    
 
}
 
}
Line 224: Line 234:
 
         <a href="https://2017.igem.org/Team:Tuebingen/Inspiration"style="margin-right:1.5em;">Inspiration</a>
 
         <a href="https://2017.igem.org/Team:Tuebingen/Inspiration"style="margin-right:1.5em;">Inspiration</a>
 
         <a href="https://2017.igem.org/Team:Tuebingen/Demonstrate"style="margin-right:1.5em;">Results</a>
 
         <a href="https://2017.igem.org/Team:Tuebingen/Demonstrate"style="margin-right:1.5em;">Results</a>
−
         <a href="https://2017.igem.org/Team:Tuebingen/HP/"style="margin-right:1.5em;">Human Practice</a>
+
         <a href="https://2017.igem.org/Team:Tuebingen/HP"style="margin-right:1.5em;">Human Practice</a>
 
         <a href="https://2017.igem.org/Team:Tuebingen/Lab"style="margin-right:1.5em;">Lab</a>
 
         <a href="https://2017.igem.org/Team:Tuebingen/Lab"style="margin-right:1.5em;">Lab</a>
 
         <a href="https://2017.igem.org/Team:Tuebingen/Attributions"style="margin-right:1.5em;">Attributions</a>
 
         <a href="https://2017.igem.org/Team:Tuebingen/Attributions"style="margin-right:1.5em;">Attributions</a>
 
       </div>
 
       </div>
 
        
 
        
−
+
  <div style="max-width:100%;">
−
          <img src="https://static.igem.org/mediawiki/2017/8/8c/T--Tuebingen--LabTitle.jpg" alt="InterLabBild" id="BigImageLab">
+
  <img src="https://static.igem.org/mediawiki/2017/8/8c/T--Tuebingen--LabTitle.jpg" alt="InterLabBild" id="BigImageLab">
 +
   
 +
  <div  style="position: absolute; text-align:right;
 +
                            margin-bottom: 10%;
 +
                            margin-left: 60%;
 +
                            margin-top:-4em;
 +
                            font-size: 3em;color:white;font-weight:light;letter-spacing: 3px;"> basic parts
 +
            </div> </div>  
 
        
 
        
 
        
 
        
Line 257: Line 274:
 
              
 
              
  
−
<p><h3><strong><a href="http://parts.igem.org/Part:BBa_K2372004">BBa_K2372004</a> </strong></h3> </p>           
+
<p><a href="http://parts.igem.org/Part:BBa_K2372004"id="BBa_K2372004" class="anchor">BBa_K2372004</a> </p>           
 
                  
 
                  
 
                 <p> SHV-1 is a β-lactamase that mediates resistance against ꞵ-lactams </p>
 
                 <p> SHV-1 is a β-lactamase that mediates resistance against ꞵ-lactams </p>
Line 264: Line 281:
  
 
                  
 
                  
−
<p> <strong> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372000">BBa_K2372000</a> </strong> </p>
+
<p> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372000"id="BBa_K2372000" class="anchor">BBa_K2372000</a> </p>
 
                  
 
                  
 
               <p> CouL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics
 
               <p> CouL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics
Line 272: Line 289:
  
  
−
               <p> <strong> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372001">BBa_K2372001</a> </strong> </p>   
+
               <p> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372001"id="BBa_K2372001" class="anchor">BBa_K2372001</a> </p>   
  
 
                  
 
                  
Line 280: Line 297:
  
  
−
<p> <strong> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372002">BBa_K2372002</a> </strong> </p>
+
<p> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372002"id="BBa_K2372002" class="anchor">BBa_K2372002</a> </strong> </p>
 
                  
 
                  
 
               <p> β-lactam synthetase (BLS) catalyzes the formation of the β-lactam ring of clavulanic acid
 
               <p> β-lactam synthetase (BLS) catalyzes the formation of the β-lactam ring of clavulanic acid
Line 287: Line 304:
 
    
 
    
  
−
<p> <strong> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372003">BBa_K2372003</a> </strong> </p>   
+
<p> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372003"id="BBa_K2372003" class="anchor">BBa_K2372003</a> </strong> </p>   
  
 
                  
 
                  
Line 294: Line 311:
  
  
−
<p> <strong> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372005">BBa_K2372005</a> </strong> </p>  
+
<p> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372005"id="BBa_K2372005" class="anchor">BBa_K2372005</a> </p>  
 
                  
 
                  
 
               <p> Gyrase B (GyrB)is a type II topoisomerase
 
               <p> Gyrase B (GyrB)is a type II topoisomerase
Line 300: Line 317:
  
 
   
 
   
−
<p> <strong> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372006">BBa_K2372006</a> </strong> </p>  
+
<p> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372006"id="BBa_K2372006" class="anchor">BBa_K2372006</a> </p>  
 
                  
 
                  
 
               <p> Gyrase B (GyrB)is a type II topoisomerase
 
               <p> Gyrase B (GyrB)is a type II topoisomerase
Line 310: Line 327:
  
  
−
 
+
<div id="ImpressumSponsoren">
 +
      <img src="https://static.igem.org/mediawiki/2017/5/58/T%C3%BCbingen_Qiagen-Logo.jpeg" id="Quiagen" width=70px>  <img src="https://static.igem.org/mediawiki/2017/1/1c/T%C3%BCbingen_Roth-Logo.jpeg" id="Roth" width=70px>  <img src="https://static.igem.org/mediawiki/2017/d/d8/TuebingenZymoLogo.jpeg" width=150px>  <img src="https://static.igem.org/mediawiki/2017/5/5b/T%C3%BCbingen_Eurofins-Logo.png" id="eurofins" width=150px>    <img src="https://static.igem.org/mediawiki/2017/e/e4/GATCTuebingen.png" id="GATC" width=150px>  <img src="https://static.igem.org/mediawiki/2017/4/49/T%C3%BCbingen_NEB-Logo.jpeg" id="BioLabs" width=150px><br><img src="https://static.igem.org/mediawiki/2017/7/7c/T%C3%BCbingen_Greiner-Logo.jpeg" id="Greiner" width=150px>  <img src="https://static.igem.org/mediawiki/2017/b/bf/T%C3%BCbingen_Agilent-Logo.jpeg" id="Agilent" width=150px>  <img src="https://static.igem.org/mediawiki/2017/0/01/T%C3%BCbingen_abcr-Logo.png" id="abcr" width=150px>  <img src="https://static.igem.org/mediawiki/2017/5/59/MicrosynthTuebingen.png" width=150px>  <img src="https://static.igem.org/mediawiki/2017/8/8b/Eppendorftuebingen.png" width=150px>
 +
        <div> <p> &copy; iGEM Team Tuebingen 2017</p></div>
  
  
 
</div>
 
</div>
 
    
 
    
 +
  
  
 
</body>
 
</body>
 
</html>
 
</html>

Latest revision as of 12:38, 12 December 2017

iGEM Tübingen 2017

Logo Trojan Horse Team Inspiration Results Human Practice Lab Attributions
InterLabBild
basic parts

Basic Parts

BBa_K2372004

SHV-1 is a β-lactamase that mediates resistance against ꞵ-lactams

BBa_K2372000

CouL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics

BBa_K2372001

CloL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics

BBa_K2372002

β-lactam synthetase (BLS) catalyzes the formation of the β-lactam ring of clavulanic acid

BBa_K2372003

The BLS mutant is a rationally designed mutant of the β-lactam synthetase

BBa_K2372005

Gyrase B (GyrB)is a type II topoisomerase

BBa_K2372006

Gyrase B (GyrB)is a type II topoisomerase


© iGEM Team Tuebingen 2017